Silexion Therapeutics 주식 (NASDAQ: SLXN)

에 대한 최신 뉴스 Silexion Therapeutics (NASDAQ:SLXN) 주식

Silexion Therapeutics

Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

BBWI

SLXN

월요일(25일) 아침 미국 주식 선물이 상승하는 가운데 오늘 투자자들의 관심을 끌 수 있는 주식 몇 가지는 다음과 같다. 배스앤바디웍스, 애질런트, 실렉시온, 우드워드 및 줌 비디오

월요일 주목해야 할 주식: 배스앤바디웍스, 애질런트, 실렉시온, 우드워드 및 줌 비디오

Silexion Therapeutics Corp - Ordinary Shares

Silexion Therapeutics Corp

Oppenheimer analyst Owen Lau maintains Coinbase Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) with a Outperform and raises the price target from $265 to $358.

Price Target

Analyst Ratings

COIN

Oppenheimer Maintains Outperform on Coinbase Glb, Raises Price Target to $358

RBC Capital analyst Scott Hanold maintains Range Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RRC#NYSE">RRC</a>) with a Sector Perform and raises the price target from $35 to $40.

RBC Capital Maintains Sector Perform on Range Resources, Raises Price Target to $40

Oppenheimer analyst Rupesh Parikh reiterates Target (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) with a Outperform and maintains $165 price target.

Reiteration

Oppenheimer Reiterates Outperform on Target, Maintains $165 Price Target

Alphabet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) and the U.S. Department of Justice are set to present closing arguments on Monday in a trial to determine if Google&#8217;s advertising technology<a href="https://www.benzinga.com/government/regulations/24/11/42143421/staggering-google-breakup-proposal-from-doj-a-kitchen-sink-moment-alphabet-analyst"> constitutes an illegal monopoly.</a>
The Details: The DOJ alleges Google maintains a monopoly in "open-web display advertising" by dominating all aspects of the marketplace with a funnel of technologies that match online publishers to advertisers as well as controls the ad exchange market, which matches the buy side to the sell side.&nbsp;
"One monopoly is bad enough. But a trifecta of monopolies is what we have here," Justice Department lawyer Julia Tarver Wood said during her opening statement.
Read More: <a href="https://www.benzinga.com/general/social-media/24/11/42119493/rumble-eyes-buying-bitcoin-could-it-be-the-next-microstrategy">Rumble CEO Considers Bitcoin Investment, Engages Michael Saylor As Shares Rally</a>
Google says that the DOJ's case is focused on a narrow niche of digital advertising and that the company's market share of 25% has been decreasing as competition has increased in the space.&nbsp;
According to the AP, court documents show that Google argues the government's case "boil(s) down to the persistent complaints of a handful of Google's rivals and several mammoth publishers."
The case is being heard by U.S. District Judge Leonie Brinkema, in Alexandria, Virginia, who is expected to decide the case and issue a written ruling by the end of the year.&nbsp;
What Else: A District of Columbia judge, in a separate case, ruled in August that Google's search engine business does constitute a monopoly. The DOJ presented its proposed remedies last week, which included the requirement for Alphabet to divest Google Chrome, the internet&#8217;s leading browser with over 60% market share globally.
Other <a href="https://www.benzinga.com/government/regulations/24/11/42119020/alphabet-bleeds-over-120-billion-in-market-value-eyes-worst-day-in-10-months-after-doj-demands-google-chrome-sale#google_vignette">proposals included</a> forcing Google to share search data with competitors, and ending default search agreements, which make Google the automatic search engine on devices and web browsers like Apple&#8217;s Safari.
&#8220;Google&#8217;s unlawful behavior has deprived rivals not only of critical distribution channels but also distribution partners who could otherwise enable entry into these markets by competitors in new and innovative ways,&#8221; the DOJ said in a statement.
The judge is expected to deliver a final decision in that case next summer.&nbsp;
Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Alphabet shares are up 1.92% at $167.92 at the time of publication Monday. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/etfs/24/11/42044642/trump-appears-frustrated-as-elon-musk-chimes-in-on-treasury-secretary-adds-more-names-to-a-list-of-potential-picks">Trump Appears &#8216;Frustrated&#8217; As Elon Musk Chimes In On Treasury Secretary, Adds More Names To Short List&nbsp;</a></li>
</ul>
Image: Shutterstock

Large Cap

Legal

Movers

Tech

GOOG

GOOGL

Google, DOJ Present Closing Arguments In AdTech Trial Monday

RBC Capital analyst Gregory Renza maintains Perspective Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CATX#AMEX">CATX</a>) with a Outperform and lowers the price target from $25 to $16.

CATX

RBC Capital Maintains Outperform on Perspective Therapeutics, Lowers Price Target to $16

WIIM

RNAZ

TransCode Therapeutics shares are trading lower after the company announced a 1-for-33 reverse stock split.

Wells Fargo analyst Roger Read maintains EQT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQT#NYSE">EQT</a>) with a Overweight and raises the price target from $42 to $52.

Wells Fargo Maintains Overweight on EQT, Raises Price Target to $52

Analog Devices's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADI#NYSE">ADI</a>) short percent of float has fallen 21.05% since its last report. The company recently reported that it has 7.43 million shares sold short, which is 1.5% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.07 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Analog Devices Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732549520_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Analog Devices has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Analog Devices's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Analog Devices's peer group average for short interest as a percentage of float is 4.84%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Peering Into Analog Devices's Recent Short Interest

Old National's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONB#NYSE">ONB</a>) short percent of float has risen 7.32% since its last report. The company recently reported that it has 9.46 million shares sold short, which is 3.81% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.3 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Old National Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732549515_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Old National has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Old National's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Old National's peer group average for short interest as a percentage of float is 3.09%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Old National's Recent Short Interest

Time's running out. The Biden administration is in a mad dash to finalize billions in CHIPS Act deals before Trump takes office. With $39 billion in funding at stake, there's no room for delays.
The CHIPS Act, signed in 2022, was supposed to bring <a href="https://www.benzinga.com/markets/equities/24/10/41387939/chipmakers-rally-nvidia-smashes-records-on-tsmc-blowout-earnings-gold-hit-all-time-highs-whats-d">chip production</a> home. The goal? Secure supply chains and cut reliance on Taiwan for advanced semiconductors. It's a big deal for U.S. manufacturing. But there's a catch. While 90% of the money is allocated, most of it hasn't been locked down yet. Only two deals, worth $6.6 billion, are fully finalized, <a href="https://www.commerce.gov/news/press-releases/2024/11/biden-harris-administration-announces-chips-incentives-award-tsmc">according to the Commerce Department.</a>
Don't Miss:
<ul>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
<li>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
</ul>
Commerce Secretary Gina Raimondo promised to allocate every dollar by the end of the year. But progress? It's been slow. And patience is wearing thin. "We are disappointed by how long and how slow the dispensing of funds has been," said Intel CEO Pat Gelsinger, as reported by Bloomberg. He's frustrated. The process has dragged on for over two years.
President Joe Biden's team is trying to speed things up. Last week, they announced<a href="https://www.benzinga.com/government/regulations/24/11/42011035/just-before-bidens-term-ends-taiwan-semiconductor-lands-6-6-billion-in-us-funding-to-build-advanced-chip-plants"> a $6.6 billion deal </a>with Taiwan's TSMC. At least $1 billion should roll out before the year ends. But there's still a lot left to sort out. Intel, the biggest potential recipient, is still negotiating terms to unlock its share.
President-elect Donald Trump, meanwhile, isn't a fan of the CHIPS Act. He's been vocal. He thinks tariffs are a better way to push companies to make chips here. On a podcast with Joe Rogan, he called tariffs the smarter move. His team might shift gears when he takes office. But here's the thing: once a CHIPS Act deal is finalized, it's tough to undo. They're legally binding unless companies don't hold up their end of the bargain.
Trending: This Jeff Bezos-backed startup will allow you to <a href="https://www.benzinga.com/money/bezos-landlord-100-dollars">become a landlord in just 10 minutes, with minimum investments as low as $100 for properties like the Byer House from Stranger Things.</a>
Analysts like Jeff Koch say Trump could slow things down, even if he doesn't scrap the CHIPS Act. "This had the ancillary benefit of pushing the Biden administration to cut through red tape and disburse CHIPS Act funds while still in power," Koch told Business Insider.
There's also pressure from the clock. January is fast approaching. Biden's team knows the window to finalize these agreements is closing. The next administration could stall or rewrite the rules, adding more uncertainty to a complicated process.
And it's not just about securing funding. There are benchmarks. <a href="https://www.benzinga.com/news/earnings/24/10/41654832/intel-likely-to-report-q3-loss-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">Companies like Intel </a>need clear terms to access the money. Another layer of bureaucracy is slowing things down. For Biden, it's a race against time to solidify the vision of the CHIPS Act before Trump's team takes over.
The stakes are high. America needs these funds locked in to compete globally. Chips power everything from smartphones to cars, so falling behind isn't an option. All eyes are on whether Biden can pull this off in time. The pressure's on and there's no room for missteps.
Read Next:
<ul>
<li>Studies show 50% of consumers think Financial Advisors cost much more than they do —<a href="https://www.benzinga.com/money/money-pickle"> to debunk this, this company provides matching for free and a complimentary first call with the matched advisor.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest TODAY for just $0.26/share with a $1000 minimum.</a></li>
</ul>

Startups

'We Are Disappointed.' Intel CEO Criticizes Delays As Biden Pushes $6.6 Billion To TSMC

Zebra Technologies's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZBRA#NYSE">ZBRA</a>) short percent of float has fallen 17.52% since its last report. The company recently reported that it has 511 thousand shares sold short, which is 1.13% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.07 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Zebra Technologies Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732549510_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Zebra Technologies has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Zebra Technologies's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Zebra Technologies's peer group average for short interest as a percentage of float is 6.77%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

ZBRA

Looking Into Zebra Technologies's Recent Short Interest

Diana Shipping shares are trading lower after the company reported worse-than-expected Q3 sales results.

IMUX

Immunic shares are trading higher after HC Wainwright initiated coverage on the stock with a Buy rating and announced a $10 price target.

Wells Fargo maintains Expand Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXE#NASDAQ">EXE</a>) with a Equal-Weight and raises the price target from $83 to $100.

Wells Fargo Maintains Equal-Weight on Expand Energy, Raises Price Target to $100

Palatin Technologies shares are trading higher after the company announced the completion of enrollment in its Phase 2 Study of PL8177.

Editor's Note: The headline has been corrected to accurately reflect the quoted material.
Elon Musk on Saturday shared a cryptic tweet on X, hinting at a significant turning point in human history.
What Happened: Musk&nbsp;responded to a post on X by Bojan Tunguz, which referred to an unspecified event as &#8220;one of the major inflection&nbsp;points of human history.&#8221; Musk&#8217;s reply was enigmatic, stating, &#8220;I knew if I brought&nbsp;a sink they would have&nbsp;to let that sink in.&nbsp;How could they not?&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">I knew if I brought a sink they would have to let that sink in. How could they not? <a href="https://t.co/voEVBMC7Ht">https://t.co/voEVBMC7Ht</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1860199022121943545?ref_src=twsrc%5Etfw">November 23, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The Tesla and SpaceX CEO&#8217;s post on X has left his followers intrigued, as they attempt to decipher the meaning behind his cryptic words.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42152684/musk-tweet-sparks-dogecoin-surge-fuels-speculation-on-x-payments">Musk Tweet Sparks Dogecoin Surge, Fuels Speculation On X Payments</a>
Why It Matters: Musk is known for his cryptic tweets, which often lead to widespread speculation. His recent tweet, which suggests a significant turning point in human history, has sparked a flurry of theories among his followers.
While the exact meaning behind Musk&#8217;s tweet remains unclear, it underscores his reputation as a thought leader in the tech industry, known for pushing boundaries and challenging conventional thinking.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/24/11/42152586/judge-rejects-sec-bid-to-penalize-musk-over-missed-deposition">Judge Rejects SEC Bid to Penalize Musk Over Missed Deposition</a></li>
</ul>
Photo: Shutterstock

Social Media

'I Knew If I Brought A Sink': What Does Elon Musk's Cryptic Tweet Mean? (CORRECTED)

B of A Securities analyst Omar Dessouky maintains AppLovin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) with a Buy and raises the price target from $252 to $375.

B of A Securities Maintains Buy on AppLovin, Raises Price Target to $375

Elon Musk recently set social media abuzz with a tweet featuring a clip from Netflix&#8217;s &#8220;Narcos,&#8221; where Pablo Escobar, portrayed by actor Wagner Moura, is seen smoking a joint. Musk captioned the post, &#8220;Actual footage of me after @realDonaldTrump won,&#8221; referring to <a href="https://www.benzinga.com/news/24/11/41768178/donald-trump-defeats-kamala-harris-to-win-2024-election">Donald Trump&#8217;s 2024 victory</a>. The tweet&#8217;s provocative nature, tying a drug kingpin character to a political celebration, triggered a range of reactions online.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Actual footage of me after <a href="https://twitter.com/realDonaldTrump?ref_src=twsrc%5Etfw">@realDonaldTrump</a> won <a href="https://t.co/PhPJjzaw0J">pic.twitter.com/PhPJjzaw0J</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1860475842800812347?ref_src=twsrc%5Etfw">November 24, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<h3 class="wp-block-heading">Musk's Cannabis Advocacy And Public Persona</h3>
Musk's selection of a cannabis-themed scene aligns with his public stance on marijuana and psychedelics. In 2018, Musk famously smoked a joint during a live appearance on &#8220;The Joe Rogan Experience,&#8221; sparking both cultural fascination and corporate scrutiny. The incident even prompted NASA to review SpaceX's workplace practices.
Beyond this, Musk has consistently supported the legalization of <a href="https://www.benzinga.com/cannabis">cannabis</a> and the therapeutic use of <a href="https://www.benzinga.com/topic/psychedelics">psychedelics</a>, recently describing them as "pretty helpful" for conditions like PTSD and depression. His tweet juxtaposes this advocacy with a tongue-in-cheek nod to cannabis culture, though some critics have questioned the appropriateness of invoking Escobar&#8217;s likeness in the context of drug reform.
<h3 class="wp-block-heading">Musk's Role In Trump's Reelection And Political Context</h3>
The tweet coincides with Musk's increasing prominence in U.S. politics. As co-leader of the Department of Government Efficiency (DOGE), a special initiative within President-elect Donald Trump's upcoming administration, Musk is tasked with identifying waste in federal operations and driving cost-cutting measures.
See also: <a href="https://www.benzinga.com/markets/cannabis/24/11/41951578/trump-taps-cannabis-supporters-elon-musk-vivek-ramaswamy-to-slash-government-spending">Trump Taps Cannabis Supporters Elon Musk, Vivek Ramaswamy To Slash Government Spending</a>
The role cements Musk's alignment with Trump's deregulatory platform, but his cannabis-friendly public image contrasts sharply with conservative perspectives on drug policy.
<h3 class="wp-block-heading">Wagner Moura's Political Views And Social Media Irony</h3>
Wagner Moura, the Brazilian actor known for his portrayal of Escobar in &#8220;Narcos,&#8221; holds progressive political views that contrast with Musk's alignment with Trump. Moura has openly <a href="https://www.yahoo.com/entertainment/wagner-moura-chasing-truth-100000406.html?utm_source=chatgpt.com&amp;guccounter=1&amp;guce_referrer=aHR0cHM6Ly9jaGF0Z3B0LmNvbS8&amp;guce_referrer_sig=AQAAAHyPGwAKPhq_ebbbAr72fKnwcPnvJS6EpQAlbqiXcPZejVhUfydhaxYD39x4-d1Xi4IZ9CYMdVNt30qS4HKVbbOP2T71GtilDmAimDnHraRNLm8zAuS3LxtiLjwBvSDS9Veg3PKX0XNT33KTYuXeq4qsqFCIZYHrN8nkqE3v-2vh">supported</a> leftist causes in Brazil and has been an outspoken critic of authoritarianism. While he has not directly criticized Trump on record, his advocacy for democratic values and opposition to leaders like Brazil's former president Jair Bolsonaro suggest ideological differences with Trump's approach.
This clash between Moura and Musk was not lost on social media. One Twitter user noted, "This actor is Brazilian. He hates Donald Trump and loves Fidel Castro," while another added, "This actor is Brazilian, liberal, and deeply hates you, Elon." Moura has not publicly commented on the incident, but the online reactions pointed out the irony of Musk's use of the clip
Photo by <a href="https://commons.wikimedia.org/wiki/User:Dmoberhaus">Daniel Oberhaus</a> via <a href="https://commons.wikimedia.org/wiki/File:Elon_Musk_at_a_Press_Conference.jpg">Wikimedia Commons</a>, edited by Benzinga

Cannabis

Politics

Did Elon Musk Really Use A Meme Of Pablo Escobar Smoking Weed To Celebrate Trump's Election Victory? What Does It Even Mean?

QNTM

Quantum BioPharma shares are trading higher after the company announced legal teams have been assembled to pursue the recovery of all losses and damages.

RBC Capital analyst Christopher Dendrinos maintains GE Vernova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) with a Outperform and raises the price target from $285 to $376.

RBC Capital Maintains Outperform on GE Vernova, Raises Price Target to $376

Biomotion Sciences (SLXN) has provided an announcement. Moringa completed its planned merger with Merger Sub 2, becoming a wholly owned subsidiary ...

Biomotion Sciences' Strategic Merger and Corporate Restructuring

Warning: SLXN is at high risk of performing badly

Naz Rahman, an analyst from Maxim Group, maintained the Buy rating on Silexion Therapeutics (SLXN – Research Report). The associated price target r...

Promising Therapeutic Advances and Strategic Positioning Make Silexion Therapeutics a Compelling Investment Opportunity

Silexion Therapeutics announces 1-for-9 reverse share split

Press Releases

Silexion Therapeutics Reports Promising Phase 2 Data for Non-Resectable Pancreatic Cancer Treatment

Silexion Therapeutics Reports Breakthroughs From SIL-204 Preclinical Studies

Silexion Therapeutics Unveils Promising Preclinical Data for SIL-204 Just Days After New LODER Data: Advancing the Fight Against Pancreatic Cancer

Market Alert: Silexion Therapeutics (NASDAQ: SLXN) Sees Record Volumes Following Breakthrough Preclinical Data for SIL-204

PetVivo (OTCQB: PETV) Revolutionizes Veterinary Medicine, Boosts Revenue, New Leadership! see more stocks inside….

Silexion Therapeutics to Present at 2024 Maxim Healthcare Virtual Summit

Silexion Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Health Care

Silexion Therapeutics to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference

Silexion Therapeutics Announces 1-for-9 Reverse Share Split

BTTC

CBDW

HOLO

PETV

SLXNW

UAVS

Aditxt

Allarity Therapeutics, Inc. - Common stock

Allarity Therapeutics

Alzamend Neuro

Aptorum Group Limited - Class A Ordinary Shares

Aptorum Gr

Aptevo Therapeutics

AquaBounty Technologies, Inc. - Common Stock

AquaBounty Techs

180 Life Sciences

Anitra

Bionomics Limited - American Depository Shares

Bionomics

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

Channel Therapeutics Corporation Common Stock

Channel Therapeutics

Carmell

Cyclerion Therapeutics, Inc. - Common Stock

Cyclerion Therapeutics

GRI Bio

Pasithea Therapeutics Corp. - Common Stock

Pasithea Therapeutics

Lixte Biotechnology Holdings, Inc. - Common Stock

Lixte Biotechnology

Organovo Holdings

Palisade Bio

Polyrizon

Portage Biotech

Protagenic Therapeutics, Inc. - Common Stock

Protagenic Therapeutics

Sunshine Biopharma

SILO Pharma

Alaunos Therapeutics, Inc. - Common Stock

Alaunos Therapeutics

Tharimmune

Maxim Group

월요일(25일) 아침 미국 주식 선물이 상승하는 가운데 오늘 투자자들의 관심을 끌 수 있는 주식 몇 가지는 다음과 같다
1. 배스앤바디웍스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBWI#NYSE">BBWI</a>)
<a href="https://pro.benzinga.com/dashboard" target="_blank" rel="noopener">벤징가 프로 데이터</a>에 따르면 오늘 개장 전 실적을 발표하는 배스앤바디웍스의 매출은 15억 8,000만 달러, 주당순이익은 47센트로 예상된다. 주가는 시간외 거래에서 2.6% 상승한 31.51달러를 기록했다.
2. 애질런트 테크놀로지스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>)
오늘 장 마감 후 실적을 발표하는 애질런트의 분기 주당순이익은 1.41달러, 매출은 16억 7천만 달러로 예상된다. 주가는 시간외 거래서 0.8% 상승한 134.96달러에서 거래되었다.
3. 실렉시온 테라퓨틱스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>)
실렉시온은 1:9 주식 병합을 발표했다. 주간는 시간외 거래서 11.2% 하락한 0.2725달러에서 거래되었다.
자세한 내용은 <a href="https://www.benzinga.com/premarket/" target="_blank" rel="noopener">프리마켓 커버리지</a>를 확인하세요.
4. 우드워드 (NASDAQ:<a class="ticker" style="font-size: revert;" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>)
오늘 장 마감 후 분기 실적을 발표하는 우드위드의 주당순이익은 1.26달러, 매출은 8억 1,101만 달러로 예상된다. 주가는 시간외 거래에서 0.3% 상승한 176.49달러에서 거래되었다.
5. 줌 비디오 커뮤니케이션스 (NASDAQ:<a class="ticker" style="font-size: revert;" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>)
오늘 장 마감 후 실적을 발표하는 줌 비디오의 분기 주당순이익은 1.31달러, 매출은 11억 6천만 달러로 예상된다. 주식은 시간외 거래에서 1.3% 상승한 86.95달러에서 거래되었다.
이 기사도 읽어보세요: <a href="https://kr.benzinga.com/news/usa/stocks/%ED%85%8C%EC%8A%AC%EB%9D%BC%EC%99%80-%EB%A6%AC%EB%B9%84%EC%95%88-%EC%98%81%EC%97%85%EB%B9%84%EB%B0%80-%EC%B9%A8%ED%95%B4-%EC%86%8C%EC%86%A1%EC%97%90%EC%84%9C-4%EB%85%84-%EB%A7%8C%EC%97%90-%ED%95%A9/" target="_blank" rel="noopener">테슬라와 리비안, 영업비밀 침해 소송에서 4년 만에 합의</a>
사진 출처: Shutterstock
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Silexion Therapeutics

뉴스

에 대한 최신 뉴스 Silexion Therapeutics (NASDAQ:SLXN) 주식

월요일, 11월 25, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌